ABSTRACT INTRODUCTION
Leber’shereditaryopticneuropathyisa neuro-ophthalmologicalentitycharacterized byacuteorsubacutebilateralvisuallossthat isusuallysequential,withcentrocecalscotoma and occasional further visual improvement. Itisassociatedwithamatrilinealinheritance pattern.Itsdiagnosisusedtobesolelyclini-cal,aidedbyimagingandneurophysiological studies, until the advent of descriptions of mitochondrial biochemical abnormalities andgenetictesting.1-3Wepresentthecaseofa
youngmalewhosesymptomswerecompatible withLeber’shereditaryopticneuropathy,as confirmedbygenetictesting.
CASEREPORT
A17-year-oldmalewasbroughttoour medicalattentioncomplainingofvisualloss. Sixmonthsearlier,hehadfirstlostsightin hislefteye,overthecourseofafewdays, untilhecouldseeonlyshadows.Oneweek later, this symptom occurred in his right eye.Atthetimeofourinitialconsultation, hesaidthathewasonlyabletoseeshadows inhisrighteye.
Thispatienthadhadgeneralizedtonic-clonicseizuresfromtheageofsevenmonths untilhewastwoyearsold,withgoodcontrol usingphenobarbital.Whenhewasachild,he hadmumpsandchickenpox.Twomaternal uncleshadhadsimilarpatternsofvisualloss, buttheydiedofnon-relateddiseases,without adefinitediagnosis,whentheywere50years old.Thepatienthadbeensmokingabout30 cigarettes/dayanddrinkingheavilyeveryday
foroneyear,buthadquitthesehabitswhen thevisualsymptomsbegan.
Neuro-ophthalmological examination revealedvisualacuityof20/800inbotheyes. The direct and consensual pupillary light reflexesweredecreased,whereastheextrinsic ocular motility was normal. A campimetric studyshowedcompletevisuallossinallfields of both eyes. Fundus examination demon-stratedpaleopticdiscs.
Thepatientwasinitiallygiventhedi-agnosisofbilateralopticneuritisand,over thelastsixmonths,hehasbeensubmitted tothefollowingtestsintheophthalmology unit:(1)visualcampimetry,whichshowed marked decrease of retina sensitivity in botheyes;(2)magneticresonanceimaging oftheskullandorbits,whichwasnormal; (3)cerebrospinalfluidexamination,which showednormalcellsabsence,glucoseof70 mg/dl,proteinsof178mg/dl,normalpro-teinelectrophoresisandalsotheoligoclonal banding;(4)visualevokedpotential(during thefirstdaysofthedisease),whichshowed discrete signs of conduction disturbances in the optic nerves; (5) retina angiofluo-rescein, which showed signs of pale optic discs bilaterally, associated with tortuous retinalvessels.Thepatientunderwentpulse therapyusingmethylprednisolone1g/day forthreedays,andmaintenancetherapyof prednisone40mg/day,withoutanyvisual improvement.
When he was admitted into our unit, we decided to perform muscle biopsy (left brachial biceps muscle), with the intention of searching for abnormalities suggestive of mitochondrialcytopathy,suchasthepresence •HélioAfonsoGhizoniTeive
•AndréRibeiroTroiano •SalmoRaskin •LineuCésarWerneck
Leber’shereditaryoptic
neuropathy–casereport
andliteraturereview
NeurologyOutpatientClinic,NeurologyService,DepartmentofInternal
Medicine,UniversidadeFederaldoParaná,Curitiba,Brazil
CONTEXT:Leber’shereditaryopticneuropathyisan important cause of progressive painless visual lossamongyoungmalepatients.
OBJECTIVE:Toreportonacaseofayoungpatient withaclinicalandneurophysiologicalcondition suggestiveofLeber’shereditaryopticneuropathy, confirmedbygenetictesting.
CASEREPORT:Wedescribea17-year-oldmalewith progressive bilateral visual loss. Two maternal uncles had had similar patterns of visual loss. Thepatienthadahistoryofsmokingandalcohol abuse. Neuro-ophthalmological examination revealedvisualacuityof20/800inbotheyes, withdecreaseddirectandconsensualpupillary lightreflexes.Fundusexaminationdemonstrated paleopticdiscs.Thevisualevokedpotentialtest showedsignsofconductiondisturbancesinboth optic nerves and campimetric study showed complete visual loss in all fields of both eyes. A diagnosis of bilateral optic neuropathy with a clinical suspicion of Leber’s hereditary optic neuropathy was made. A blood sample was submitted to genetic analysis in relation to the principalmutationsofthisdisorder,andhomo-plasmicmutationin11778wasdetected,thereby confirming the diagnosis of Leber’s hereditary opticneuropathy.
KEY WORDS:Optic neuropathy. Optic nerve diseases. Optic atrophy. Mitochondrial DNA. Visualacuity.
C
aseR
epor
t
SãoPauloMedicalJournal—RevistaPaulistadeMedicina
277
ofragged-redfibers.Theresultswereabnormal butnonspecific,withatrophyoffibertypes 1 and 2. Our clinical suspicion of Leber’s hereditary optic neuropathy remained high andabloodsamplewasthereforesubmitted togeneticanalysisinrelationtotheprincipal mutationsofthisdisorder.
After DNA extraction from peripheral blood cells, using traditional methods, we proceededwithmolecularanalysistoinves-tigatefourprimarypointsofmitochondrial DNA (11778, 3460, 14484 and 15257). These were analyzed using the polymerase chainreaction(PCR),restrictionenzymedi-gestionofDNA(restrictionfragmentlength polymorphism) and the direct sequencing method, under the conditions depicted in Table1.Homoplasmicmutationin11778 wasdetected,therebyconfirmingourdiag-nostichypothesis.
Duringoutpatientfollow-up,hissymp-toms have not increased or decreased, and hehasbeenmedicatedusingvitaminC(500 mgt.i.d.),vitaminB1(5mg),vitaminB2(2 mg),vitaminB6(2mg),vitaminPP(20mg), vitaminB5(3mg),inonetablet,t.i.d,and coenzymeQ10(100mgb.i.d.).Thepurpose ofthissupplementationwastoimprovecel-lularATPusage.
DISCUSSION
Hereditaryopticneuropathiesareagroup ofdiseaseswithdefinedclinicalpresentation anddifferentinheritancepatterns.Theclinical settingmaybeofacute,sub-acuteorrelent-lesslyprogressivepainlessvisualloss,bilateral (simultaneousorsequential),withcentrocecal scotoma, altered color perception (dyschro-matopsia)andopticatrophy.Theinheritance patternmaypresentasautosomallydominant, recessive,X-linkedormatrilineal.1
InLeber’shereditaryopticneuropathy, maleindividualsintheirteensortwenties sufferacutevisuallossthatissequentialin 78% of cases and simultaneous in 22%.2
Fundus examination in the initial stages shows papilledema and peripapillary mi-croangiopathy, evolving to atrophy of the
nerve fiber layer of the retina and finally leading to optic atrophy and centrocecal scotoma.3 Family history is suggestive of
maternal inheritance in 50% of patients, andintheother50%thediseaseseemsto besporadic.2,4
Four main mutations of mitochondrial DNA (mtDNA) encompass over 90% of patientswithLeber’shereditaryopticneuropa-thy: 11778 (genetic subunit ND4), 14484 (ND6),3460(ND1)and14459(ND6).The mutation at 14459 corresponds to the dys-toniaphenotypeforLeber’shereditaryoptic neuropathy.2,5 Mashima et al.6 assessed the
prevalenceofdifferentmutationsinasample of80individualswithLeber’shereditaryoptic neuropathyandshowedthat87%carriedthe mutationat11778,9%at14484and4%at 3460.Riordan-Evaetal.2foundprevalences
forthesamemutationsofrespectively75%, 15%and8%.Orientalstudiesdemonstrate higherproportionsof11778mutationsthan doWesternstudies.6,7Biousseetal.8reported
the 14484 mutation on monozygotic twins with distinct phenotypes (only one symp-tomaticsibling),whilegenetictestinginthe mother was negative, thereby suggestingde novomutation.
Sadunetal.recentlypublishedanexten-siveinvestigationofalargeBrazilianlineage of11778/haplogroupJwithLeber’shereditary opticneuropathy.Theauthorsemphasizedthe stronginfluenceofenvironmentalriskfactors, withsmokingasthemostcommonfactor.9
Eighty-five percent of patients with Leber’s hereditary optic neuropathy are homoplasmic for mtDNA mutations; the remaining 15% are heteroplasmic. The relationship between heteroplasmy levels and clinical condition was studied by Chinnery et al.,10 who showed that
het-eroplasmicpatientswithhigherdegreesof mutantmtDNAhadagreaterprobability ofdevelopingvisualloss.Womencarrying upto80%mutantmtDNAarelessprone tohavesymptomaticsonsthanarehomo-plasmicwomen.Nevertheless,thishasbeen refuted by Huoponen,3 on the basis that
heteroplasmylevelsprobablydifferbetween
nervecellsandwhitebloodcells.Moreover, environmentalinfluencesalsocontributeto theopticnervedamage.
Secondarymutationssuchas3394,4216, 4917,5244,7444,9438,13708and15257 havebeenstudiedwithregardtothegenesis ofLeber’shereditaryopticneuropathy.Recent studieshavenotfoundanydifferenceinthe prevalence of secondary mutations between individuals with Leber’s hereditary optic neuropathyandthecontrolgroup.6,7
Multiplesclerosis(orMS-likedisease) shares a rather uncommon comorbidity with Leber’s hereditary optic neuropathy. SomepatientswithLeber’shereditaryoptic neuropathy develop clinical features that are phenotypically indistinguishable from multiplesclerosis,andmutationsforLeber’s neuropathy are considered to be a risk factor in the pathophysiology of multiple sclerosis.11
On the other hand, prevalence studies amongmultiplesclerosispatientshavefailed to demonstrate primary mtDNA muta-tions.12,13It is currently recommended to
proceedwithmtDNAanalysisforallyoung male multiple sclerosis patients with initial neuro-ophthalmological manifestations and peripapillary microangiopathy, especially thosewithbilateralsymptomsandapositive familyhistoryforvisualloss.14
There is no specific treatment for Leber’shereditaryopticneuropathy.From an empirical standpoint, most if not all patientswillreceiveaninitialdiagnosisof opticneuritisandwillbetreated,without any response, using steroid therapy at high doses. In a case-control study with patients carrying mutations 14484, 3460 and 11778, combination therapy using idebenone/vitamin B2/vitamin C (which improves ATP availability) shortened the time required for vision recovery in the groupusingthistherapy(11.1months),in comparisonwiththeplacebogroup(17.4 months;p=0.03).15Asingle-patientstudy
backedbymagneticresonancespectroscopy ofthecentralnervoussystem(31P-MRS) showedclinicalandimagingimprovement
Table1.TestingconditionsforpolymerasechainreactionforthedetectionofmitochondrialDNAmutationsinacase ofLeber’shereditaryopticneuropathy
Mutation Method Fragment Hybridization Enzyme Incubation Detection
G11778A RFLP 11325–12209(1008) 56°C MaeIII 1H-55°C Acrylamide8%
G3460A RFLP 3201–3600(399) 62°C BsaHI 1-2H–37°C Acrylamide8%
G14484A RFLP 14401–14510(109) 56°C BsrI 1H-65°C Acrylamide11%
Sequencing 13901–14976(1075) 58°C primersequencing
T15257 RFLP 14401–15927(1526) 58°C AccI 1-2H–37°C Agarose1%
RFLP=Restrictionfragmentlengthpolymorphism.
SãoPauloMedicalJournal—RevistaPaulistadeMedicina
278
1. KerrisonJB.Hereditaryopticneuropathies.OphthalmolClin NorthAm.2001;14(1):99-107.
2. Riordan-EvaP,SandersMD,GovanGG,SweeneyMD,Da CostaJ,HardingAE.TheclinicalfeaturesofLeber’shereditary opticneuropathydefinedbythepresenceofapathogenicmito-chondrialDNAmutation.Brain.1995;118(Pt2):319-37. 3. HuoponenK.Leberhereditaryopticneuropathy:clinicaland
moleculargeneticfindings.Neurogenetics.2001;3(3):119-25. 4. YamadaK,MashimaY,KigasawaK,MiyashitaK,Wakakura
M,OguchiY.Highincidenceofvisualrecoveryamongfour JapanesepatientswithLeber’shereditaryopticneuropathywith the14484mutation.JNeuroophthalmol.1997;17(2):103-7. 5. BrownMD,AllenJC,VanStavernGP,NewmanNJ,Wallace
DC. Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the11778and14484primarymutations.AmJMedGenet. 2001;104(4):331-8.
6. Mashima Y, Yamada K, Wakakura M, et al. Spectrum of pathogenicmitochondrialDNAmutationsandclinicalfeatures inJapanesefamilieswithLeber’shereditaryopticneuropathy. CurrEyeRes.1998;17(4):403-8.
7. YenMY,WangAG,ChangWL,HsuWM,LiuJH,WeiYH. Leber’shereditaryopticneuropathy–thespectrumofmitochon-drialDNAmutationsinChinesepatients.JpnJOphthalmol. 2002;46(1):45-51.
8. Biousse V, Brown MD, Newman NJ, et al.De novo 14484 mitochondrial DNA mutation in monozygotic twins dis-cordant for Leber’s hereditary optic neuropathy. Neurology. 1997;49(4):1136-8.
9. Sadun AA, Carelli V, Salomão SR, et al. Extensive investi-gation of a large Brazilian pedigree of 11778/haplogroup J Leber hereditary optic neuropathy. Am J Ophthalmol. 2003;136(2):231-8.
10. ChinneryPF,AndrewsRM,TurnbullDM,HowellNN.Leber hereditaryopticneuropathy:Doesheteroplasmyinfluencethe inheritanceandexpressionoftheG11778AmitochondrialDNA mutation?AmJMedGenet.2001;98(3):235-43. 11. Vanopdenbosch L, Dubois B, D’Hooghe MB, Meire F,
Carton H. Mitochondrial mutations of Leber’s hereditary opticneuropathy:ariskfactorformultiplesclerosis.JNeurol. 2000;247(7):535-43.
12. Pénisson-BesnierI,MoreauC,JacquesC,RogerJC,DubasF,
ReynierP.Scléroseenplaquesetmutationsdel’ADNmito-chondrialassociéesàlamaladiedeLeber.[Multiplesclerosis andLeber’shereditaryopticneuropathymitochondrialDNA mutations].RevNeurol(Paris).2001;157(5):537-41. 13. KalmanB,LublinFD,AlderH.MitochondrialDNAmutations
inmultiplesclerosis.MultScler.1995;1(1):32-6. 14. MojonDS,HerbertJ,SadiqSA,MillerJR,MadonnaM,Hirano
M.Leber’shereditaryopticneuropathymitochondrialDNA mutationsatnucleotides11778and3460inmultiplesclerosis. Ophthalmologica.1999;213(3):171-5.
15. MashimaY,KigasawaK,WakakuraM,OguchiY.Doidebenone andvitamintherapyshortenthetimetoachievevisualrecovery in Leber hereditary optic neuropathy? J Neuroophthalmol. 2000;20(3):166-70.
16. CortelliP,MontagnaP,PierangeliG,etal.Clinicalandbrain bioenergeticsimprovementwithidebenoneinapatientwith Leber’shereditaryopticneuropathy:aclinicaland31P-MRS study.JNeurolSci.1997;148(1):25-31.
17. NakamuraM,YamamotoM.Variablepatternofvisualrecov-eryofLeber’shereditaryopticneuropathy.BrJOphthalmol. 2000;84(5):534-5.
when idebenone treatment was instituted (idebenone is not available in Brazil, but only in Argentina: its action is similar to thatofthecoenzymeQ10).16
The prognosis for vision recovery depends on the mutation reported. Good prognosismaybefoundinupto50%ofpa-
tientsbearingthe14484mutation.Never-theless,only4%ofpatientswiththe11778 mutationhavegradualimprovement,aswe wereabletoobserveinourpatient.2,17
CONCLUSION
A diagnosis of Leber’s hereditary optic neuropathy should be suspected whenever
youngmalesdevelopbilateralvisualloss,usu- allysequential,withapositivefamilialhis-tory. Neuro-ophthalmological examination maydemonstratesuggestivesignsofLeber’s hereditaryopticneuropathy.Themutation at the 11778 locus is the most frequent mutationofmitochondrialDNAinLeber’s hereditaryopticneuropathypatients.
REFERENCES
SãoPauloMedicalJournal—RevistaPaulistadeMedicina
279
PUBLISHINGINFORMATION
HélioAfonsoGhizoniTeive .Assistantprofessorofneu-rology,NeurologyService-InternalMedicineDepartment, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba,Paraná,Brazil.
AndréRibeiroTroiano .Neurologist,NeurologyService- InternalMedicineDepartment,HospitaldeClínicas,Univer-sidadeFederaldoParaná,Curitiba,Paraná,Brazil.
SalmoRaskin.Geneticistphysician,GenetikaLaboratory, Curitiba,Paraná,Brazil.
Lineu César Werneck. Head of Neurology Service, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba,Paraná,Brazil.
Sourcesoffunding:None
Conflictofinterest:None
Dateoffirstsubmission:January20,2004
Lastreceived:August3,2004
Accepted:August10,2004
Addressforcorrespondence:
HélioAfonsoGhizoniTeive
R.GeneralCarneiro,1103/102—Centro Curitiba(PR)—Brasil—CEP80060-150. Tel./Fax(+5541)244-5060
E-mail:[email protected]
COPYRIGHT©2004,AssociaçãoPaulistadeMedicina
NeuropatiaópticahereditáriadeLeber–relato decasoerevisãodaliteratura
CONTEXTO: A neuropatia óptica hereditária de Leber representa uma importante causa de perda visual progressiva, sem dor, em pacientesjovensdosexomasculino. OBJETIVO:Relatarocasodeumpacientejovem
comquadroclínicoeneurofisiológicosugesti-vodeneuropatiaópticahereditáriadeLeber, confirmadopelotestegenético.
RELATODECASO:Jovemdosexomasculino com 17 anos de idade com perda visual bilateralprogressivatinhahistóriafamiliar de perda visual progressiva em dois tios maternos. O paciente tinha antecedentes detabagismoealcoolismopesado.Oexame neuro-oftalmológicodemonstrouacuidade visualde20/800emambososolhos,com
diminuiçãodosreflexospupilaresdiretoe consensualepalidezdepapilasópticasno examedefundodeolho.Oexamedepo-tencialvisualevocadodefiniudistúrbiode conduçãoemambososnervosópticos.O examedecampimetriavisualrevelouperda visualcompletaemtodososcamposvisuais deambososolhos.Opacientefoidiagnosti-cadocomneuropatiaópticabilateral,coma suspeitaclínicadeneuropatiaópticaheredi- táriadeLeber,eoestudogenéticoparaaava-liaçãodasprincipaismutaçõesencontradas nestadoençarevelouapresençadamutação homoplásmica11778,confirmando,desta forma,odiagnósticodeneuropatiaóptica hereditáriadeLeber.
PALAVRAS-CHAVE: Neuropatia óptica. Do-ençasdonervoóptico.Atrofiaóptica.DNA mitocondrial.Acuidadevisual.
RESUMO